Innovative therapeutics

Investors

SEC Filings

NASDAQBMRN
FormDescriptionDateFormat
4Statement of changes in beneficial ownership of securitiesDec 26, 2007View HTMLDownload DOCDownload PDF
UPLOADCorrespondence from the SEC to the FilerDec 20, 2007Download DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesDec 20, 2007View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesDec 19, 2007View HTMLDownload DOCDownload PDF
8-KReport of unscheduled material events or corporate eventDec 13, 2007View HTMLDownload DOCDownload PDFDownload XLS
4Statement of changes in beneficial ownership of securitiesNov 21, 2007View HTMLDownload DOCDownload PDF
10-QQuarterly report which provides a continuing view of a company's financial positionNov 5, 2007View HTMLDownload DOCDownload PDFDownload XLS
8-KReport of unscheduled material events or corporate eventNov 1, 2007View HTMLDownload DOCDownload PDFDownload XLS
4Statement of changes in beneficial ownership of securitiesOct 25, 2007View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesOct 23, 2007View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesOct 15, 2007View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesOct 12, 2007View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesOct 12, 2007View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesOct 3, 2007View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesOct 3, 2007View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesOct 2, 2007View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesOct 2, 2007View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesSep 27, 2007View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesSep 26, 2007View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesSep 24, 2007View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesSep 20, 2007View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesSep 18, 2007View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesSep 18, 2007View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesSep 18, 2007View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesSep 7, 2007View HTMLDownload DOCDownload PDF
1-25      26-50      51-75      76-98

BioMarin

Diseases

Lysosomal Storage Disorders (MPS I, MPS IVA, MPS VI, CLN2 disease) PKU, LEMS

Products

Palynziq™
Brineura™
Vimizim®
Kuvan®
Naglazyme®
Aldurazyme®
Firdapse®

Patient/Physician Support Contact Information

BioMarin RareConnections
Tel: 866.906.6100
Fax: 888.863.3361
E-mail: support@biomarin-rareconnections.com

Global Medical Information

Contact Global Medical Information